Disc Medicine Opco (NASDAQ:IRON – Get Free Report) and Spruce Biosciences (NASDAQ:SPRB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Analyst Recommendations This is a breakdown […]
Disc Medicine Opco Inc (NASDAQ:IRON – Get Free Report) Director Kevin Bitterman sold 72,931 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $52.40, for a total value of $3,821,584.40. Following the transaction, the director now directly owns 882,224 shares in […]
Disc Medicine Opco Inc (NASDAQ:IRON – Get Free Report) insider William Jacob Savage sold 7,672 shares of the firm’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $52.95, for a total value of $406,232.40. The transaction was disclosed in a document filed with the Securities & […]
Disc Medicine Opco Inc (NASDAQ:IRON – Get Free Report) insider William Jacob Savage sold 7,672 shares of Disc Medicine Opco stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $52.95, for a total transaction of $406,232.40. The sale was disclosed in a filing with the Securities & […]
Disc Medicine Opco (NASDAQ:IRON – Get Free Report) released its earnings results on Friday. The company reported ($0.74) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.86) by $0.12, MarketWatch Earnings reports. Disc Medicine Opco Stock Performance NASDAQ:IRON opened at $52.92 on Monday. The stock’s fifty day moving average price is […]